fda ind, page-57

it was on the smell of an oily rag, when Sue Mc had to work out of the loungeroom, whilst every penny was saved for the Nucleonics and Re-exam legal actions.

Something that doesn't get recounted when BLT management get compared with Alny. 6 year delay! Not helpful for a biotech esp one in field of the up until recent history much maligned gene therapy. Alny never had that hurdle either, despite semantics about what is and isn't GT.

to be less than a month from clinical start, i'm grateful, and in a way, amazed.